Medanta Duke Research Institute (MDRI)

Gurgaon, Haryana 122001

0 studies enrolling now · 1 studies all time

What they study most

Advanced Refractory Solid Tumors

Studies at this site

• Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors — Paused